Bayer AG's stock demonstrated modest trading activity on Friday, settling at €21.80 with a marginal decline of 0.3%. Trading within a narrow corridor, the stock fluctuated between €21.76 and €21.94, ...

Bayer AG's stock exhibited a cautiously positive trend in Wednesday's trading, navigating within a narrow range of €21.28 to €21.77 on XETRA. The trading volume remained substantial with over 2.4 ...

News of a significant earnings beat propelled Regeneron Pharmaceuticals (NASDAQ: REGN) to a nearly 5% share price gain on the ...

Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €22.00. The ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

On January 14, 2025, Bayer Aktiengesellschaft (OTC:BAYRY) stock closed at $5.05 per share with a market capitalization of $20.162 billion. Oakmark International Fund stated the following regarding ...

Despite largely missing Ebitda and net profit compared to the street's estimate, brokerage firms continue to remain positive on the agrochemical stock in the long run.

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Learn more about whether Ultragenyx Pharmaceutical Inc. or Vericel Corporation is a better investment based on AAII's A+ ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...